<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cherney AH</submitter><funding>Camille and Henry Dreyfus Foundation</funding><funding>American Cancer Society</funding><funding>Amgen</funding><funding>DuPont</funding><funding>Alfred P. Sloan Foundation</funding><funding>National Institute of General Medical Sciences</funding><funding>Eli Lilly and Company</funding><funding>NIGMS NIH HHS</funding><funding>Division of Graduate Education</funding><funding>Novartis</funding><pagination>14365-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4210114</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>136(41)</volume><pubmed_abstract>A Ni-catalyzed asymmetric reductive cross-coupling between vinyl bromides and benzyl chlorides has been developed. This method provides direct access to enantioenriched products bearing aryl-substituted tertiary allylic stereogenic centers from simple, stable starting materials. A broad substrate scope is achieved under mild reaction conditions that preclude the pregeneration of organometallic reagents and the regioselectivity issues commonly associated with asymmetric allylic arylation.</pubmed_abstract><journal>Journal of the American Chemical Society</journal><pubmed_title>Nickel-catalyzed asymmetric reductive cross-coupling between vinyl and benzyl electrophiles.</pubmed_title><pmcid>PMC4210114</pmcid><funding_grant_id>R01 GM111805</funding_grant_id><funding_grant_id>DGE-1144469</funding_grant_id><funding_grant_id>GM111805-01</funding_grant_id><pubmed_authors>Reisman SE</pubmed_authors><pubmed_authors>Cherney AH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nickel-catalyzed asymmetric reductive cross-coupling between vinyl and benzyl electrophiles.</name><description>A Ni-catalyzed asymmetric reductive cross-coupling between vinyl bromides and benzyl chlorides has been developed. This method provides direct access to enantioenriched products bearing aryl-substituted tertiary allylic stereogenic centers from simple, stable starting materials. A broad substrate scope is achieved under mild reaction conditions that preclude the pregeneration of organometallic reagents and the regioselectivity issues commonly associated with asymmetric allylic arylation.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Oct</publication><modification>2025-04-22T21:09:46.878Z</modification><creation>2019-03-27T01:38:23Z</creation></dates><accession>S-EPMC4210114</accession><cross_references><pubmed>25245492</pubmed><doi>10.1021/ja508067c</doi></cross_references></HashMap>